CRO

A two-day in person event packed with leading speakers, research and cutting-edge presentations on RNA-based therapeutic medicines, formulation and delivery of mRNA, RNAi and siRNA therapeutics. Experience case studies, technical presentations, and interactive discussions on the latest breakthroughs in this promising area of drug development.

The Scientific Program features a diverse range of scientific sessions organized into two concurrent themed tracks covering issues such as Novel In Vitro and In Silico Assays to Predict Human Safety, In Vivo and Ex vivo Case Studies For Safety, Debate on the “Value” of Primary Tissue and In Vivo Studies and are disease Models Relevant in Safety Pharmacology, Macro Molecules Science: Antibodies, Oligo, and Peptides, Translation Beyond FIH Exposure Response Models, Macro Molecules Science: Gene therapy, Cell Therapy, mRNA and PROTAC, Derisking and Risk Mitigation Strategies, Clinical Cardiology, and much more! This will ensure attendees can stay abreast of new content and developments in key areas of interest. 

With more than 6,500 toxicologists from all over the world expected to attend, opportunities for networking and finding new collaborators are abundant—from the Scientific Sessions and other daytime events through the evening receptions. Research organizations, government agencies, drug developers, regulatory authorities, academic institutions, laboratory and medical suppliers, or consultants are encouraged to exhibit at ToxExpo.

The RDD conference series impacts regulatory and scientific policies worldwide and is recognized as one of the premier international meetings in this area. Its success is founded on the selection of internationally renowned speakers addressing salient topics in pulmonary and nasal drug delivery, lively audience participation, and the financial support of organizations with a proven commitment to, and record of, innovation in the field of inhalation aerosols.

RAPS Convergence is the largest and most well-recognized annual gathering of regulatory professionals, scientists, and innovators in the world. Convergence brings together representatives from industry, global regulatory bodies, and research, academic and clinical organizations that are directly involved in managing the regulatory process and aligning science, regulation, and business strategy.

A dedicated 2-day hybrid meeting with a focus on paving the road to laboratory
digitalisation through automation, robotics and cutting-edge informatics tools & technologies. 3 interactive tracks aiding the acceleration of laboratory digitalisation within the pharmaceutical industry: from setting up the labs of the future through to the application of automation and robotics & the implementation of state of-the-art IT tools and technologies.

PharmaSUG is the premier event of the year for statistical programmers, statisticians, data managers, researchers, and others who analyze data in the life sciences.   The programmers who used to attend this conference are now managers, directors, and executives. These individuals are now also involved in statistics, data management, and regulatory submission preparation. As you will see below, the attendees represent the technical and executive leadership covering pharmaceutical, biotechnology,
and the CRO industry. 

Patients as Partners® specializes in the relationship between pharma clinical operations and patients and patient advocacy in how to drive greater clinical efficiencies and great value for all stakeholders.

Co-produced with industry, patients and public-sector voices, the Patients as Partners events are the only conferences that demonstrate how Pharma can involve patients throughout the entire clinical development life cycle to drive greater efficiencies in clinical research.  The conferences delve into patient engagement ideas, strategies, partnerships, and tools to advance patient participation and achieve better outcomes in trials.